Influence of the antagonist of the glycine site of NMDA receptors, MRZ 2/576, on the anticonvulsant activity of conventional antiepileptic drugs in mice

Pharmacological Reports

Volumn 57, Issue 4, 2005, Pages 458-466

  Makarska Białek, Katarzyna ^a   Kamiński, Rafał M ^b,c   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Antiepileptic drugs; Glycine site antagonists; Mice; MRZ 2 576; NMDA receptor; Seizures

Indexed keywords

8 CHLORO 4 HYDROXY 1 OXO 1,2 DIHYDROPYRIDAZINO[4,5]QUINOLIN 5 OXIDE CHOLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; LUMINALUM NATRIUM; MRZ 2576; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXCARBAZEPINE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROATE MAGNESIUM; VALPROIC ACID;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENTIATION; ELECTRIC SHOCK; LOW DRUG DOSE; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; SEIZURE;

EID: 24744444141     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boissier JR, Tardy J, Diverres JC: Une nouvelle methode simple pour explorer l'action tranquilisante. Le test de la cheminee. Med Exp Basel, 1960, 3, 81-84.
2. Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ: Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice. Epilepsia, 1996, 37, 618-624.
3. Borowicz KK, Stasiuk G, Teter J, Kleinrok Z, Gasior M, Czuczwar SJ: Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice. J Neural Transm, 2000, 107, 733-743.
4. Czechowska G, Dziki M, Pietrasiewicz T, Kleinrok Z, Turski WA, Czuczwar SJ: Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice. Eur J Pharmacol, 1993, 232, 59-64.
5. Czuczwar SJ: Experimental background for synergistic and additive effects of antiepileptic drugs. Epileptologia, 1998, 6, Suppl 2, 21-29.
6. Czuczwar SJ: Perspectives for the use of excitatory amino acid inotropic receptor antagonists as antiepileptic drugs. Pol J Pharmacol, 2000, 52, 67-70.
7. Danysz W, Parsons CG: Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev, 1998, 50, 597-664.
8. Danysz W, Parsons CG, Karcz-Kubicha M, Schwaier A, Popik P, Wedzony K, Lazarewicz J et al.: GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids, 1998, 14, 235-239.
9. Hesselink MB, Smolders H, Eilbacher B, De Boer AG, Breimer DD, Danysz W: The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies. J Pharmacol Exp Ther, 1999, 290, 543-550.
10. Kamiński R, Przywara B, Gasior M, Kleinrok Z, Czuczwar SJ: Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs. J Neural Transm, 1998, 105, 133-146.
11. Kamiński R, Wolińska E, Gasior M, Kleinrok Z, Czuczwar SJ: NMDA receptor glycine site antagonist (indole-2-carboxylic acid) enhances the anticonvulsive activity of antiepileptic drugs. Neurosci Res Commun, 1998, 22, 137-145.
12. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
13. Löscher W, Rundfeldt C, Honack D: Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur J Neurosci, 1993, 5, 1545-1550.
14. Löscher W, Schmidt D: Which animal models should be used in the search for new antiepileptic drugs? A proposal based on the experimental and clinical considerations. Epilepsy Res, 1988, 2, 145-181.
15. Nichols AC, Yielding KL: Anticonvulsant activity of antagonist for the NMDA-associated glycine binding site. Mol Chem Neuropathol, 1993, 19, 269-281.
16. Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg L, Baran L et al.: Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterisation. J Pharmacol Exp Ther, 1997, 283, 1264-1275.
17. Pietrasiewicz T, Czechowska G, Dziki M, Turski WA, Kleinrok Z, Czuczwar SJ: Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics. Eur J Pharmacol, 1993, 250, 1-7.
18. Schumacher TB, Beck H, Steinhauser C, Schramm J, Elger CE: Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia, 1998, 39, 355-363.
19. Sopala M, Schweizer S, Schafer N, Nurnberg E, Kreuter J, Seiller E, Danysz W: Neuroprotective activity of a nanoparticulate formulation of the glycineB site antagonist MRZ 2/576 in transient focal ischaemia in rats. Arzneimittelforschung, 2002, 52, 168-174.
20. Sveinbjornsdottir S, Sander JW, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M et al.: The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res, 1993, 16, 165-174.
21. Urbańska EM, Czuczwar SJ, Kleinrok Z, Turski WA: Excitatory amino acids in epilepsy. Restor Neurol Neurosci, 1998, 13, 25-39.
22. Venault P, Chapouthier G, de Carvalho LP, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature, 1986, 321, 864-866.
23. Wenk GL, Baker LM, Stoehr JD, Hauss-Wegrzyniak B, Danysz W: Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites. Eur J Pharmacol, 1998, 347, 183-187.
24. White HS: Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia, 1999, 40, Suppl 5, S2-S10.
25. Wlaź P, Loscher W: Weak anticonvulsant effects of two novel glycineB receptor antagonists in the amygdalakindling model in rats. Eur J Pharmacol, 1998, 342, 39-46.
26. Wlaź P, Roliński Z, Czuczwar SJ: Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice. Epilepsia, 1996, 37, 610-617.
27. Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ: The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice. Neuropharmacology, 1994, 33, 619-624.